Efficacy and safety of erdafitinib in adults with cholangiocarcinoma (CCA) with prespecified fibroblast growth factor receptor alterations (FGFRalt) in the phase 2 open-label, single-arm RAGNAR trial: Expansion cohort results.
| Autor: | Pant, Shubham, Schuler, Martin H., Iyer, Gopa, Doi, Toshihiko, Qin, Shukui, Tabernero, Josep, Arnold, Dirk, Gutierrez, Martin, Prenen, Hans, Folprecht, Gunnar, Winter, Helen, Cosman, Rasha, Zibetti Dal Molin, Graziela, Xia, Qi, Najmi, Saltanat, Hammond, Constance, Thomas, Shibu, Triantos, Spyros, Sweiti, Hussein, Loriot, Yohann |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2/1/2023 Supplement 1, Vol. 41, p610-610, 1p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|